Board RE - Search Results

1

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.

Board RE, Ellison G, Orr MC, Kemsley KR, McWalter G, Blockley LY, Dearden SP, Morris C, Ranson M, Cantarini MV, Dive C, Hughes A. Board RE, et al. Br J Cancer. 2009 Nov 17;101(10):1724-30. doi: 10.1038/sj.bjc.6605371. Epub 2009 Oct 27. Br J Cancer. 2009. PMID: 19861964 Free PMC article. Clinical Trial.

2

Circulating tumour-derived predictive biomarkers in oncology.

Hodgson DR, Wellings R, Orr MC, McCormack R, Malone M, Board RE, Cantarini MV. Hodgson DR, et al. Among authors: board re. Drug Discov Today. 2010 Feb;15(3-4):98-101. doi: 10.1016/j.drudis.2009.12.006. Epub 2010 Jan 4. Drug Discov Today. 2010. PMID: 20045486 Review.

3

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.

Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, Board R, Clack G, Hughes A, Blackhall F, Valle JW, Dive C. Khoja L, et al. Br J Cancer. 2012 Jan 31;106(3):508-16. doi: 10.1038/bjc.2011.545. Epub 2011 Dec 20. Br J Cancer. 2012. PMID: 22187035 Free PMC article.

4

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer.

Board RE, Wardley AM, Dixon JM, Armstrong AC, Howell S, Renshaw L, Donald E, Greystoke A, Ranson M, Hughes A, Dive C. Board RE, et al. Breast Cancer Res Treat. 2010 Apr;120(2):461-7. doi: 10.1007/s10549-010-0747-9. Epub 2010 Jan 28. Breast Cancer Res Treat. 2010. PMID: 20107891

5

Multiplexed assays for detection of mutations in PIK3CA.

Board RE, Thelwell NJ, Ravetto PF, Little S, Ranson M, Dive C, Hughes A, Whitcombe D. Board RE, et al. Clin Chem. 2008 Apr;54(4):757-60. doi: 10.1373/clinchem.2007.098376. Clin Chem. 2008. PMID: 18375489

6

Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer.

Board RE, Williams VS, Knight L, Shaw J, Greystoke A, Ranson M, Dive C, Blackhall FH, Hughes A. Board RE, et al. Ann N Y Acad Sci. 2008 Aug;1137:98-107. doi: 10.1196/annals.1448.020. Ann N Y Acad Sci. 2008. PMID: 18837931

7

Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours.

Aung KL, Board RE, Ellison G, Donald E, Ward T, Clack G, Ranson M, Hughes A, Newman W, Dive C. Aung KL, et al. Among authors: board re. Hugo J. 2010 Dec;4(1-4):11-21. doi: 10.1007/s11568-011-9149-2. Epub 2011 Jan 30. Hugo J. 2010. PMID: 22132062 Free PMC article.

8

Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy.

Hou JM, Greystoke A, Lancashire L, Cummings J, Ward T, Board R, Amir E, Hughes S, Krebs M, Hughes A, Ranson M, Lorigan P, Dive C, Blackhall FH. Hou JM, et al. Am J Pathol. 2009 Aug;175(2):808-16. doi: 10.2353/ajpath.2009.090078. Epub 2009 Jul 23. Am J Pathol. 2009. PMID: 19628770 Free PMC article.

9

DNA methylation in circulating tumour DNA as a biomarker for cancer.

Board RE, Knight L, Greystoke A, Blackhall FH, Hughes A, Dive C, Ranson M. Board RE, et al. Biomark Insights. 2008 Jan 25;2:307-19. Biomark Insights. 2008. PMID: 19662228 Free PMC article.

10

The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.

Murrell J, Board R. Murrell J, et al. Cancer Treat Rev. 2013 Dec;39(8):833-8. doi: 10.1016/j.ctrv.2013.06.004. Epub 2013 Jul 9. Cancer Treat Rev. 2013. PMID: 23845462 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters